Skip to main content
Premium Trial:

Request an Annual Quote

Protelica Wins $500K NSF Bioinformatics Grant

NEW YORK (GenomeWeb News) — The National Science Foundation has given Protelica a $500,000 grant to continue developing its DNA mutagenesis technologies in a bioinformatics-based project aimed at developing protein therapies, the company said today.

Protelica will use the two-year, Phase II Small Business Innovation Research funding to develop "a bioinformatics-based understanding of nature’s evolutionary rules, and utilizes Protelica's proprietary DNA mutagenesis technologies to develop small, specific and potent protein blockers," the company said.

This grant is part of a project that began two years ago called "Bioinformatics knowledge-based, universal library design for a non-immunoglobulin, protein-scaffold," according to the Hayward, Calif.-based company.

Protelica CEO and CSO Roberto Crea said in a statement that the firm expects the project to lead to the discovery and development of "new protein therapeutics that may replace the first generation monoclonal antibody drugs."

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.